Enzymotec

Bio-functional lipid ingredients and final products for nutritional and pharmaceutical application

placeKfar Saba, Central District, Israel calendar_todayFounded 1998 groups235 employees language enzymotec.com

Innovation

44 patent families (27 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 3,130 times.

YearFilings
201312
201410
201512
201621
201719
201815
20198
20206
202111
20222
20232
20241

Investor mix

11 investors on record; lead investors include TPY Capital, Ofer-Hi Tech, Millennium Materials Technologies Fund, Galam.

Investor typeCountShare
Venture capital545%
Private equity218%
Other / undisclosed436%
Coming soon